D[LEU4,LYS8]-VP TFA; 纯度: 98.16%
D[LEU4,LYS8]-VP TFA 是血管加压素 V1b 受体的选择性激动剂,对大鼠,人类和小鼠 V1b 受体的 Ki 值分别为 0.16 nM,0.52 nM 和 1.38 nM。D[LEU4,LYS8]-VP TFA 具有较弱的抗利尿剂、升压药和体外催产素活性。
D[LEU4,LYS8]-VP TFA Chemical Structure
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
5 mg | ¥800 | In-stock | |
10 mg | ¥1300 | In-stock | |
50 mg | ; | 询价 | ; |
100 mg | ; | 询价 | ; |
* Please select Quantity before adding items.
D[LEU4,LYS8]-VP TFA 相关产品
bull;相关化合物库:
- Bioactive Compound Library Plus
- GPCR/G Protein Compound Library
- Macrocyclic Compound Library
- Anti-Cardiovascular Disease Compound Library
- Peptide Library
生物活性 |
D[LEU4,LYS8]-VP TFA is a selective agonist of vasopressin V1b receptor, with the Kis of 0.16 nM, 0.52 nM, and 0.1.38 nM for rat, human and mouse V1b receptor, respectively. D[LEU4,LYS8]-VP TFA has weak antidiuretic, vasopressor, and in vitro oxytocic activities[1][2]. |
IC50 Target |
vasopressin V1b receptor[1] |
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
分子量 |
1140.25 |
||||||||||||||||||||
Formula |
C49H68F3N11O13S2 |
||||||||||||||||||||
Sequence |
{Mpa}-Tyr-Phe-Leu-Asn-Cys-Pro-Lys-Gly (Disulfide bridge:Mpa1-Cys6) |
||||||||||||||||||||
Sequence Shortening |
{Mpa}-YFLNCPKG-NH2 (Disulfide bridge:Mpa1-Cys6) |
||||||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||||||
储存方式 |
Sealed storage, away from moisture
*In solvent : -80deg;C, 6 months; -20deg;C, 1 month (sealed storage, away from moisture) |
||||||||||||||||||||
Solvent Solubility |
In Vitro:;
H2O Peptide Solubility and Storage Guidelines: 1.;;Calculate the length of the peptide. 2.;;Calculate the overall charge of the entire peptide according to the following table:
3.;;Recommended solution:
|
||||||||||||||||||||
参考文献 |
|